| Memantine - Wikipedia, the free encyclopedia Memantine is the first in a novel class of Alzheimer's disease medications acting on the glutamatergic system by blocking NMDA glutamate receptors. It was first ... Read More |
| Login - memantine.com Login. On this website healthcare professionals find detailed information on memantine by Merz and Alzheimer's Disease. Only healthcare professionals can be given ... Read More |
| memantine medical facts from Drugs.com Physician reviewed memantine patient information - includes memantine description, dosage and directions. Read More |
| memantine (Namenda) - drug class, medical uses, medication side ... Specifies the medication memantine (Namenda), a drug used for the treatment of moderate to severe dementia of the Alzheimer's type. Read More |
| Memantine - PubMed Health - National Center for Biotechnology ... Memantine is used to treat the symptoms of Alzheimer's disease. Memantine is in a class of medications called NMDA receptor antagonists. It works by ... Read More |
| Memantine: MedlinePlus Drug Information - National Library of ... Memantine is used to treat the symptoms of Alzheimer's disease. Memantine is in a class of medications called NMDA receptor antagonists. It works by ... Read More |
| Namenda (Memantine HCL) Drug Information: Description, User ... Learn about the prescription medication Namenda (Memantine HCL), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| Memantine - International Antiaging Systems - Tomorrow's ... Memantine regulates glutamate, a chemical involved in information processing, storage and retrieval. Read More |
| Namenda (memantine HCl) – Official Site Namenda (memantine HCl) - Learn more about Namenda and find information for patients and caregivers including Namenda side effects, treatments, indications, FAQs and ... Read More |
| Memantine - Home - SciTopics Introduction Memantine (1-amino-3,5-dimethyladamantane) (Fig. 1) is a moderate affinity, uncompetitive NMDA receptor antagonist and is approved for the ... Read More |
